<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Am J Trop Med Hyg</journal-id>
      <journal-id journal-id-type="publisher-id">tpmd</journal-id>
      <journal-title-group>
        <journal-title>The American Journal of Tropical Medicine and Hygiene</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0002-9637</issn>
      <issn pub-type="epub">1476-1645</issn>
      <publisher>
        <publisher-name>The American Society of Tropical Medicine and Hygiene</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">21118941</article-id>
      <article-id pub-id-type="pmc">2990051</article-id>
      <article-id pub-id-type="doi">10.4269/ajtmh.2010.10-0271</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Articles</subject>
        </subj-group>
        <series-title>Case Report</series-title>
      </article-categories>
      <title-group>
        <article-title>Tuberculosis Pericarditis with Cardiac Tamponade: Management in the Resource-Limited Setting</article-title>
        <alt-title alt-title-type="left-running-head">HELLER AND OTHERS</alt-title>
        <alt-title alt-title-type="right-running-head">TB PERICARDITIS IN RESOURCE-LIMITED SETTING</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Heller</surname>
            <given-names>Tom</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lessells</surname>
            <given-names>Richard J.</given-names>
          </name>
          <xref ref-type="corresp" rid="COR1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wallrauch</surname>
            <given-names>Claudia</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brunetti</surname>
            <given-names>Enrico</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff id="AFF1">Hlabisa Hospital, Hlabisa, KwaZulu-Natal, South Africa; Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Mtubatuba, KwaZulu-Natal, South Africa; Division of Infectious and Tropical Diseases, University of Pavia, San Matteo Hospital Foundation, Pavia, Italy</aff>
      <author-notes>
        <corresp id="COR1">*Address correspondence to Richard J. Lessells, Africa Centre for Health and Population Studies, University of KwaZulu-Natal, PO Box 198, Mtubatuba, KwaZulu-Natal 3935, South Africa. E-mail: <email>rlessells@africacentre.ac.za</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>06</day>
        <month>12</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>06</day>
        <month>12</month>
        <year>2010</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="ppub"/>. -->
      <volume>83</volume>
      <issue>6</issue>
      <fpage>1311</fpage>
      <lpage>1314</lpage>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>5</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>16</day>
          <month>6</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;The American Society of Tropical Medicine and Hygiene</copyright-statement>
        <copyright-year>2010</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/">
          <license-p>This is an Open Access article distributed under the terms of the American Society of Tropical Medicine and Hygiene's Re-use License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>We report a case of human immunodeficiency virus&#x2013;associated pericardial tuberculosis complicated by cardiac tamponade. Emergency management and subsequent therapeutic interventions are described and then discussed with particular focus on resource-limited settings. The paucity of evidence to support clinical decisions is emphasized and the need for well designed diagnostic and therapeutic studies is highlighted.</p>
      </abstract>
    </article-meta>
    <notes notes-type="disclaimer">
      <p>Note: Supplementary videos are available at <ext-link ext-link-type="uri" xlink:href="www.ajtmh.org">www.ajtmh.org</ext-link>.</p>
    </notes>
  </front>
  <body>
    <p>The convergence of human immunodeficiency virus (HIV) and tuberculosis (TB) epidemics in southern Africa has contributed to a significant increase in reported cases of extrapulmonary TB (EPTB).<xref ref-type="bibr" rid="R1">1</xref> One of the most common presentations of disease is pericardial TB, which in HIV co-infection is associated with significant mortality and morbidity.<xref ref-type="bibr" rid="R2">2</xref> Cardiac tamponade is a common and life-threatening complication of TB pericarditis that requires immediate medical intervention.</p>
    <p>We report a case of TB pericarditis associated with HIV infection and its management in Hlabisa Hospital, a rural district hospital in northern KwaZulu-Natal, South Africa. Hlabisa is located at the epicenter of the intertwined HIV and TB epidemics: the prevalence of HIV is 21.5% in the adult population (15&#x2013;49 years of age); the TB notification rate was 1,700 per 100,000 persons in 2008; and the HIV co-infection rate for TB patients is 76%.<xref ref-type="bibr" rid="R3">3</xref> We discuss the identification and management of this condition in HIV-infected persons, with a focus on settings with limited resources for diagnosis and intervention. We highlight some of the key areas where further evidence is required to inform clinical practice.</p>
    <sec sec-type="cases" id="s1">
      <title>Case Report</title>
      <p>A 34-year old HIV-infected man (CD4 cell count = 310 cells/mm<sup>3</sup>) came to our hospital with a short history of increasing dyspnea and dizziness. He reported chest pain, weight loss, night sweats, but no cough. On initial assessment, he was unwell, diaphoretic, tachycardic (heart rate = 128/min), hypotensive (blood pressure = 100/60 mm of Hg), and severely tachypnoeic (respiratory rate = 40/min). Jugular venous pressure was increased. Chest radiograph demonstrated enlarged cardiac shadow. Because echocardiography was available on site, ultrasound was performed using a conventional B-Mode ultrasound scanner (Just Vision 400; Toshiba, Tokyo, Japan) with a 3.5-MHz abdominal probe and a sub-xiphoidal approach. A 3&#x2013;4 cm pericardial effusion was seen, with impaired filling of the right ventricle and right atrium, the characteristic sonographic signs of cardiac tamponade (<xref ref-type="fig" rid="F1">Figure 1</xref> and Supplementary Video 1).</p>
      <fig id="F1" position="float">
        <label>Figure 1.</label>
        <caption>
          <p>Ultrasound at presentation for the patient, showing large pericardial effusion and right ventricular collapse.</p>
        </caption>
        <graphic xlink:href="tropmed-83-1311-g001"/>
      </fig>
      <p>The patient was transferred to the high care unit for pericardiocentesis and continuous electrocardiography (ECG) monitoring. No dedicated pericardiocentesis set or central venous cannula was available at that time. Localization for intercostal puncture approximately in the mid-clavicular line was determined by using ultrasound, and a 16-gauge intravenous cannula was inserted in the lower portion of the intercostal space. The needle was removed and 400 mL of clear yellow fluid was drained before removal. Despite the persistence of a large effusion, cardiac function improved significantly, and the clinical status improved significantly within thirty minutes (<xref ref-type="fig" rid="F2">Figure 2</xref> and Supplementary Video 2). Anti-tuberculous therapy (Rifafour<sup>&#xAE;</sup>; Sanofi-Aventis, Midrand, South Africa, four tablets/day, a fixed-dose combination of rifampicin, isoniazid, ethambutol, and pyrazinamide)) and treatment with prednisolone (80 mg/day) were commenced. After two days, the condition had stabilized and the patient requested discharge; at this time the effusion measured 1&#x2013;2 cm (<xref ref-type="fig" rid="F3">Figure 3</xref>). Prednisolone was prescribed for one month and continued TB therapy was supervised at the primary health care clinic. After two months, antiretroviral therapy (stavudine/lamivudine/efavirenz) was initiated. The six-month course of antituberculous therapy was completed uneventfully with no evidence of immune reconstitution inflammatory syndrome and ultrasound at the end of treatment demonstrated no residual pericardial effusion.</p>
      <fig id="F2" position="float">
        <label>Figure 2.</label>
        <caption>
          <p>Ultrasound post-pericardiocentesis for the patient, showing persistent large effusion but improved right ventricular filling.</p>
        </caption>
        <graphic xlink:href="tropmed-83-1311-g002"/>
      </fig>
      <fig id="F3" position="float">
        <label>Figure 3.</label>
        <caption>
          <p>Ultrasound on day 3 for the patient, showing reduction in pericardial effusion.</p>
        </caption>
        <graphic xlink:href="tropmed-83-1311-g003"/>
      </fig>
    </sec>
    <sec sec-type="discussion" id="s2">
      <title>Discussion</title>
      <p>Clinical manifestations of pericarditis (chest pain, cough, dyspnea) overlap with other disease entities in HIV-infected persons: most importantly pulmonary and pleural TB, but also bacterial pneumonia and <italic>Pneumocystis jiroveci</italic> pneumonia. Systemic signs (weight loss, night sweats, fatigue) may be present but are non-discriminatory. Signs of heart failure may result from progression of pericardial effusion but HIV-infected persons are also more likely to have myocardial involvement and hemodynamic instability.<xref ref-type="bibr" rid="R4">4</xref></p>
      <p>A high index of suspicion for pericardial disease is therefore required in symptomatic HIV-infected persons, and it is important that imaging is included in algorithms for smear-negative and extrapulmonary TB.<xref ref-type="bibr" rid="R5">5</xref> Although expansion of radiographic facilities would be welcomed, we would also like to see more extensive use of ultrasound techniques. Although cardiomegaly observed by chest radiograph is suggestive of pericardial effusion, distinction from dilated cardiomyopathy requires ultrasound and formal echocardiography is rarely available in the district hospital setting. Recognition of the anechoic effusion is normally straightforward; thickened pericardium with echogenic, exudative coating and fibrin strands may be seen and increases the likelihood of tuberculous etiology.<xref ref-type="bibr" rid="R6">6</xref> If expertise is available, it is also important to assess the right ventricular cavity because in cases of tamponade the diameter will be reduced and there might be a paradoxical inward motion or even collapse of the free wall.</p>
      <p>Preliminary work from our group suggests that non-specialist physicians can be trained to identify key features of EPTB by using ultrasound.<xref ref-type="bibr" rid="R7">7</xref> However, pericardial effusion was a common finding in HIV-infected patients in this study and further research is required to establish clinical decision&#x2013;making tools based on clinical features and sonographic appearance.</p>
      <p>In countries with a high prevalence of TB, this disease has been reported as the cause of more than 90% of large pericardial effusions in HIV-infected persons.<xref ref-type="bibr" rid="R8">8</xref> Other potential causes include bacterial pericarditis (e.g., non-typhoidal <italic>Salmonella</italic>), human herpesvirus-8&#x2013;related disease, and lymphoma. Definitive diagnosis of tuberculous etiology is challenging because studies have shown the yield from direct smear examination of pericardial fluid to be as low as 2%<xref ref-type="bibr" rid="R9">9</xref>; culture of pericardial fluid is positive in 38&#x2013;56% of cases.<xref ref-type="bibr" rid="R9">9</xref>,<xref ref-type="bibr" rid="R10">10</xref> Other indirect methods used to support TB diagnosis, such as adenosine deaminase levels in pericardial fluid, have the limitation of lower sensitivity in persons with advanced HIV infection.<xref ref-type="bibr" rid="R11">11</xref> All diagnostic studies have the common problem of the lack of a definitive gold standard. Whether novel diagnostic technologies that use the polymerase chain reaction have sufficient accuracy with samples such as pericardial fluid requires well-designed studies.</p>
      <p>In the absence of sufficiently rapid, accurate diagnostic techniques, it is appropriate in high prevalence areas to initiate empiric antituberculous therapy in the presence of large pericardial effusion. Diagnostic pericardial aspiration should be reserved for cases where there is evidence for an alternative diagnosis (e.g., skin lesions of Kaposi's sarcoma) or suspicion of drug-resistant TB.</p>
      <p>Pericardiocentesis is often a life-saving intervention and is essential in patients with cardiac tamponade. In clinical studies, the proportion of patients with tamponade has ranged between 20% and 90% depending on the selection of patients and definition of tamponade.<xref ref-type="bibr" rid="R4">4</xref>,<xref ref-type="bibr" rid="R12">12</xref> Cardiac tamponade is classically a clinical diagnosis characterized by increased jugular venous pressure, hypotension, and diminished heart sounds but cardiac ultrasound may identify typical features such as collapse of the right ventricle or right atrium.</p>
      <p>According to standard protocols, a needle attached to the V<sub>1</sub> lead of an electrocardiograph machine is inserted into the pericardial space, commonly by a sub-xiphoidal approach. Echocardiographic control is recommended but the expertise is unlikely to be available in many settings. In settings where dedicated pericardiocentesis equipment is not available, the use of alternative approaches, such as intercostal approach with a simple cannula as described in our case, might be necessary but should be guided by ultrasound (<xref ref-type="fig" rid="F4">Figure 4</xref>). It is necessary to drain only enough fluid to relieve the signs of hemodynamic instability. Many patients experience rapid clinical improvement despite the continuing presence of pericardial effusion. It is worth remembering that the aim is reduction of pressure in the pericardial space not volume <italic>per se</italic> and the drainage of 50&#x2013;100 mL of fluid might suffice for resolution of tamponade.</p>
      <fig id="F4" position="float">
        <label>Figure 4.</label>
        <caption>
          <p>Sites for pericardiocentesis. <bold>A</bold>, Standard sub-xiphoidal approach. <bold>B</bold>, Intercostal approach used with ultrasound guidance in this case.</p>
        </caption>
        <graphic xlink:href="tropmed-83-1311-g004"/>
      </fig>
      <p>Antituberculous therapy should be commenced as soon as a diagnosis of pericarditis is made in a setting with high prevalence of TB and HIV infection. Treatment regimens recommended for pericardial TB are the same as for pulmonary TB, consisting of rifampicin, isoniazid, ethambutol, and pyrazinamide for two months, followed by rifampicin and isoniazid for four months.<xref ref-type="bibr" rid="R13">13</xref> The paucity of data informing the treatment of TB/HIV co-infection has recently been highlighted, with particular uncertainty for duration of therapy.<xref ref-type="bibr" rid="R14">14</xref> This is particularly striking for EPTB and it is crucial that common forms of EPTB are adequately represented in future trials of antituberculous therapy.</p>
      <p>Corticosteroids are frequently prescribed for TB pericarditis but the evidence to support their use in HIV-infected patients is limited. Studies conducted in the pre-HIV era suggested significant reduction in mortality with steroids in pericardial effusion and constrictive pericarditis.<xref ref-type="bibr" rid="R15">15</xref>,<xref ref-type="bibr" rid="R16">16</xref> However, HIV infection influences the pathologic process and evidence suggests that constrictive pericarditis is much less common. The only randomized trial in HIV-infected patients included only 58 patients and showed a non-significant trend to lower mortality with adjunctive steroids.<xref ref-type="bibr" rid="R10">10</xref> A Cochrane review on this topic concluded that prednisolone has no proven beneficial effect in patients with TB pericarditis.<xref ref-type="bibr" rid="R17">17</xref> An ongoing multicentre randomized trial aims to address this key question.<xref ref-type="bibr" rid="R18">18</xref></p>
      <p>It is important to remember that because rifampicin increases corticosteroid metabolism through hepatic enzyme induction, higher doses might be required.<xref ref-type="bibr" rid="R19">19</xref> Prednisolone doses as high as 120 mg have been used successfully in treating patients with TB pericarditis.<xref ref-type="bibr" rid="R20">20</xref></p>
      <p>Pericardial TB is a World Health Organization stage IV condition and thus antiretroviral therapy is indicated regardless of CD4+ lymphocyte count.<xref ref-type="bibr" rid="R21">21</xref> There is recent evidence to support the early initiation of combination antiretroviral therapy (ART) during antituberculous therapy for pulmonary TB, although the optimal time to start has yet to be determined.<xref ref-type="bibr" rid="R22">22</xref> Patients with EPTB were not included in this trial and only observational data including patients with EPTB support the benefit of early antiretroviral therapy in this context.<xref ref-type="bibr" rid="R23">23</xref></p>
      <p>The potential risks of early ART initiation include drug toxicity, drug interactions, and immune reconstitution inflammatory syndrome. The occurrence of pericardial TB&#x2013;immune reconstitution inflammatory syndrome has been reported but the morbidity or mortality associated with this is unknown.<xref ref-type="bibr" rid="R24">24</xref> Theoretically, immune reconstitution could lead to re-accumulation of fluid (with the possibility of tamponade) and/or a higher risk of constrictive pericarditis. Our practice is to initiate ART after 2&#x2013;8 weeks of TB treatment and, as far as possible, to monitor the clinical status closely.</p>
    </sec>
    <sec sec-type="conclusions" id="s3">
      <title>Conclusions</title>
      <p>Pericardial TB is a frequent manifestation of HIV-associated TB and is associated with considerable mortality and morbidity. Many questions remain in terms of optimal diagnosis and therapy for this condition. As we progress into a new era of TB diagnostics and therapeutics to address this public health emergency, it is imperative that clinical trials include patients with extrapulmonary TB to answer some of the questions highlighted here.</p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary Material</title>
      <supplementary-material content-type="local-data" id="SD6">
        <caption>
          <title>Supplementary Videos</title>
        </caption>
        <media xlink:href="SD6.pdf" xlink:type="simple" id="d32e310" position="anchor" mimetype="application" mime-subtype="pdf"/>
      </supplementary-material>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary Material</title>
      <supplementary-material content-type="local-data" id="SD9">
        <caption>
          <title>Supplementary Videos</title>
        </caption>
        <media xlink:href="SD9.mpg" xlink:type="simple" id="d32e318" position="anchor" mimetype="video" mime-subtype="mpeg"/>
      </supplementary-material>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary Material</title>
      <supplementary-material content-type="local-data" id="SD10">
        <caption>
          <title>Supplementary Videos</title>
        </caption>
        <media xlink:href="SD10.mpg" xlink:type="simple" id="d32e326" position="anchor" mimetype="video" mime-subtype="mpeg"/>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="FN1" fn-type="supported-by">
        <p>Financial support: The Africa Centre for Health and Population Studies is supported by the Wellcome Trust.</p>
      </fn>
      <fn id="FN2" fn-type="present-address">
        <p>Authors' addresses: Tom Heller, Hlabisa Hospital, Hlabisa, KwaZulu-Natal, South Africa, E-mail: <email>echnatom@web.de</email>. Richard J. Lessells and Claudia Wallrauch, Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Mtubatuba, KwaZulu-Natal, South Africa, E-mails: <email>rlessells@africacentre.ac.za</email> and <email>claudiawallrauch@web.de</email>. Enrico Brunetti, Division of Infectious and Tropical Diseases, University of Pavia, S. Matteo Hospital Foundation, Pavia, Italy, E-mail: <email>enricobrunetti@unipv.it</email>.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="R1">
        <label>1.</label>
        <mixed-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>World Health Organization</collab>
          </person-group>
          <year>2009</year>
          <source>Global Tuberculosis Control: Epidemiology, Planning, Financing: WHO report 2009</source>
          <publisher-loc>Geneva</publisher-loc>
          <publisher-name>World Health Organization</publisher-name>
        </mixed-citation>
      </ref>
      <ref id="R2">
        <label>2.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mayosi</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Wiysonge</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Ntsekhe</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gumedze</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Volmink</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Maartens</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Aje</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Awotedu</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Thembela</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Mntla</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Maritz</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Blackett</surname>
              <given-names>KN</given-names>
            </name>
            <name>
              <surname>Nkouonlack</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Burch</surname>
              <given-names>VC</given-names>
            </name>
            <name>
              <surname>Rebe</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Parrish</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sliwa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Vezi</surname>
              <given-names>BZ</given-names>
            </name>
            <name>
              <surname>Alam</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Gould</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Visser</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Magula</surname>
              <given-names>NP</given-names>
            </name>
            <name>
              <surname>Commerford</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <year>2008</year>
          <article-title>Mortality in patients treated for tuberculous pericarditis in sub-Saharan Africa</article-title>
          <source>S Afr Med J</source>
          <volume>98</volume>
          <fpage>36</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">18270639</pub-id>
        </mixed-citation>
      </ref>
      <ref id="R3">
        <label>3.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wallrauch</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Heller</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Lessells</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kekana</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Barnighausen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Newell</surname>
              <given-names>ML</given-names>
            </name>
          </person-group>
          <year>2010</year>
          <article-title>High uptake of HIV testing for tuberculosis patients in an integrated primary health care HIV/TB programme in rural KwaZulu-Natal</article-title>
          <source>S Afr Med J</source>
          <volume>100</volume>
          <fpage>146</fpage>
          <lpage>147</lpage>
          <pub-id pub-id-type="pmid">20459930</pub-id>
        </mixed-citation>
      </ref>
      <ref id="R4">
        <label>4.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mayosi</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Wiysonge</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Ntsekhe</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Volmink</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Gumedze</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Maartens</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Aje</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Awotedu</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Thembela</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Mntla</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Maritz</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Blackett</surname>
              <given-names>KN</given-names>
            </name>
            <name>
              <surname>Nkouonlack</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Burch</surname>
              <given-names>VC</given-names>
            </name>
            <name>
              <surname>Rebe</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Parish</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sliwa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Vezi</surname>
              <given-names>BZ</given-names>
            </name>
            <name>
              <surname>Alam</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Gould</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Visser</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Shey</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Magula</surname>
              <given-names>NP</given-names>
            </name>
            <name>
              <surname>Commerford</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <year>2006</year>
          <article-title>Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) Registry</article-title>
          <source>BMC Infect Dis</source>
          <volume>6</volume>
          <fpage>2</fpage>
          <pub-id pub-id-type="pmid">16396690</pub-id>
        </mixed-citation>
      </ref>
      <ref id="R5">
        <label>5.</label>
        <mixed-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>World Health Organization</collab>
          </person-group>
          <year>2007</year>
          <source>Improving the Diagnosis and Treatment of Smear-Negative Pulmonary and Extrapulmonary Tuberculosis among Adults and Adolescents. Recommendations for HIV-Prevalent and Resource-Constrained Settings</source>
          <publisher-loc>Geneva</publisher-loc>
          <publisher-name>World Health Organization</publisher-name>
        </mixed-citation>
      </ref>
      <ref id="R6">
        <label>6.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>George</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Salama</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Uthaman</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Cherian</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <year>2004</year>
          <article-title>Echocardiography in differentiating tuberculous from chronic idiopathic pericardial effusion</article-title>
          <source>Heart</source>
          <volume>90</volume>
          <fpage>1338</fpage>
          <lpage>1339</lpage>
          <pub-id pub-id-type="pmid">15486140</pub-id>
        </mixed-citation>
      </ref>
      <ref id="R7">
        <label>7.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heller</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wallrauch</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lessells</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Goblirsch</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Brunetti</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <year>2010</year>
          <article-title>Short course for focused assessment with sonography for human immunodeficiency virus/tuberculosis: preliminary results in a rural setting in South Africa with high prevalence of human immunodeficiency virus and tuberculosis</article-title>
          <source>Am J Trop Med Hyg</source>
          <volume>82</volume>
          <fpage>512</fpage>
          <lpage>515</lpage>
          <pub-id pub-id-type="pmid">20207884</pub-id>
        </mixed-citation>
      </ref>
      <ref id="R8">
        <label>8.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reuter</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Burgess</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Doubell</surname>
              <given-names>AF</given-names>
            </name>
          </person-group>
          <year>2005</year>
          <article-title>Epidemiology of pericardial effusions at a large academic hospital in South Africa</article-title>
          <source>Epidemiol Infect</source>
          <volume>133</volume>
          <fpage>393</fpage>
          <lpage>399</lpage>
          <pub-id pub-id-type="pmid">15962545</pub-id>
        </mixed-citation>
      </ref>
      <ref id="R9">
        <label>9.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reuter</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Burgess</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>van Vuuren</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Doubell</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <year>2006</year>
          <article-title>Diagnosing tuberculous pericarditis</article-title>
          <source>QJM</source>
          <volume>99</volume>
          <fpage>827</fpage>
          <lpage>839</lpage>
          <pub-id pub-id-type="pmid">17121764</pub-id>
        </mixed-citation>
      </ref>
      <ref id="R10">
        <label>10.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hakim</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Ternouth</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Mushangi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Siziya</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Robertson</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Malin</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <year>2000</year>
          <article-title>Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients</article-title>
          <source>Heart</source>
          <volume>84</volume>
          <fpage>183</fpage>
          <lpage>188</lpage>
          <pub-id pub-id-type="pmid">10908256</pub-id>
        </mixed-citation>
      </ref>
      <ref id="R11">
        <label>11.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tuon</surname>
              <given-names>FF</given-names>
            </name>
            <name>
              <surname>Litvoc</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Lopes</surname>
              <given-names>MI</given-names>
            </name>
          </person-group>
          <year>2006</year>
          <article-title>Adenosine deaminase and tuberculous pericarditis&#x2013;a systematic review with meta-analysis</article-title>
          <source>Acta Trop</source>
          <volume>99</volume>
          <fpage>67</fpage>
          <lpage>74</lpage>
          <pub-id pub-id-type="pmid">16950165</pub-id>
        </mixed-citation>
      </ref>
      <ref id="R12">
        <label>12.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reuter</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Burgess</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Louw</surname>
              <given-names>VJ</given-names>
            </name>
            <name>
              <surname>Doubell</surname>
              <given-names>AF</given-names>
            </name>
          </person-group>
          <year>2007</year>
          <article-title>The management of tuberculous pericardial effusion: experience in 233 consecutive patients</article-title>
          <source>Cardiovasc J S Afr</source>
          <volume>18</volume>
          <fpage>20</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="pmid">17392991</pub-id>
        </mixed-citation>
      </ref>
      <ref id="R13">
        <label>13.</label>
        <mixed-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>World Health Organization, Stop TB Department</collab>
          </person-group>
          <year>2010</year>
          <source>Treatment of Tuberculosis: Guidelines</source>
          <publisher-loc>Geneva</publisher-loc>
          <publisher-name>World Health Organization</publisher-name>
        </mixed-citation>
      </ref>
      <ref id="R14">
        <label>14.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khan</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Minion</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pai</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Royce</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Burman</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Harries</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Menzies</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <year>2010</year>
          <article-title>Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis</article-title>
          <source>Clin Infect Dis</source>
          <volume>50</volume>
          <fpage>1288</fpage>
          <lpage>1299</lpage>
          <pub-id pub-id-type="pmid">20353364</pub-id>
        </mixed-citation>
      </ref>
      <ref id="R15">
        <label>15.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Strang</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Kakaza</surname>
              <given-names>HH</given-names>
            </name>
            <name>
              <surname>Gibson</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Allen</surname>
              <given-names>BW</given-names>
            </name>
            <name>
              <surname>Mitchison</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Girling</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Nunn</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Fox</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <year>1988</year>
          <article-title>Controlled clinical trial of complete open surgical drainage and of prednisolone in treatment of tuberculous pericardial effusion in Transkei</article-title>
          <source>Lancet</source>
          <volume>2</volume>
          <fpage>759</fpage>
          <lpage>764</lpage>
          <pub-id pub-id-type="pmid">2901610</pub-id>
        </mixed-citation>
      </ref>
      <ref id="R16">
        <label>16.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Strang</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Kakaza</surname>
              <given-names>HH</given-names>
            </name>
            <name>
              <surname>Gibson</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Girling</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Nunn</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Fox</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <year>1987</year>
          <article-title>Controlled trial of prednisolone as adjuvant in treatment of tuberculous constrictive pericarditis in Transkei</article-title>
          <source>Lancet</source>
          <volume>2</volume>
          <fpage>1418</fpage>
          <lpage>1422</lpage>
          <pub-id pub-id-type="pmid">2891992</pub-id>
        </mixed-citation>
      </ref>
      <ref id="R17">
        <label>17.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mayosi</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Ntsekhe</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Volmink</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Commerford</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <year>2002</year>
          <article-title>Interventions for treating tuberculous pericarditis</article-title>
          <source>Cochrane Database Syst Rev</source>
          <fpage>CD000526</fpage>
          <pub-id pub-id-type="pmid">12519546</pub-id>
        </mixed-citation>
      </ref>
      <ref id="R18">
        <label>18.</label>
        <mixed-citation publication-type="webpage">
          <person-group person-group-type="author">
            <collab>National Institutes of Health</collab>
          </person-group>
          <year>2010</year>
          <source>A Pilot Trial of Adjunctive Prednisolone and Mycobacterium w Immunotherapy in Tuberculous Pericarditis (IMPI)</source>
          <comment>Available at</comment>
          <ext-link ext-link-type="uri" xlink:href="http://clinicaltrials.gov/ct2/show/NCT00810849">http://clinicaltrials.gov/ct2/show/NCT00810849</ext-link>
          <comment>Accessed April 28, 2010</comment>
        </mixed-citation>
      </ref>
      <ref id="R19">
        <label>19.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McAllister</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Al-Habet</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Rogers</surname>
              <given-names>HJ</given-names>
            </name>
          </person-group>
          <year>1983</year>
          <article-title>Rifampicin reduces effectiveness and bioavailability of prednisolone</article-title>
          <source>Br Med J (Clin Res Ed)</source>
          <volume>286</volume>
          <fpage>923</fpage>
          <lpage>925</lpage>
        </mixed-citation>
      </ref>
      <ref id="R20">
        <label>20.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Strang</surname>
              <given-names>JI</given-names>
            </name>
          </person-group>
          <year>1994</year>
          <article-title>Rapid resolution of tuberculous pericardial effusions with high dose prednisone and anti-tuberculous drugs</article-title>
          <source>J Infect</source>
          <volume>28</volume>
          <fpage>251</fpage>
          <lpage>254</lpage>
          <pub-id pub-id-type="pmid">8089513</pub-id>
        </mixed-citation>
      </ref>
      <ref id="R21">
        <label>21.</label>
        <mixed-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>World Health Organization</collab>
          </person-group>
          <year>2007</year>
          <source>WHO Case Definitions of HIV for Surveillance and Revised Clinical Staging and Immunological Classification of HIV-Related Disease in Adults and Children</source>
          <publisher-loc>Geneva</publisher-loc>
          <publisher-name>World Health Organization</publisher-name>
        </mixed-citation>
      </ref>
      <ref id="R22">
        <label>22.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abdool Karim</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Naidoo</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Grobler</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Padayatchi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Baxter</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gray</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gengiah</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nair</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bamber</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pienaar</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>El-Sadr</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Friedland</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Abdool Karim</surname>
              <given-names>Q</given-names>
            </name>
          </person-group>
          <year>2010</year>
          <article-title>Timing of initiation of antiretroviral drugs during tuberculosis therapy</article-title>
          <source>N Engl J Med</source>
          <volume>362</volume>
          <fpage>697</fpage>
          <lpage>706</lpage>
          <pub-id pub-id-type="pmid">20181971</pub-id>
        </mixed-citation>
      </ref>
      <ref id="R23">
        <label>23.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Velasco</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Castilla</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Sanz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gaspar</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Condes</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Barros</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Cervero</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Torres</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Guijarro</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <year>2009</year>
          <article-title>Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis</article-title>
          <source>J Acquir Immune Defic Syndr</source>
          <volume>50</volume>
          <fpage>148</fpage>
          <lpage>152</lpage>
          <pub-id pub-id-type="pmid">19131895</pub-id>
        </mixed-citation>
      </ref>
      <ref id="R24">
        <label>24.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meintjes</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Rangaka</surname>
              <given-names>MX</given-names>
            </name>
            <name>
              <surname>Maartens</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Rebe</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Morroni</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Pepper</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Wilkinson</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Wilkinson</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <year>2009</year>
          <article-title>Novel relationship between tuberculosis immune reconstitution inflammatory syndrome and antitubercular drug resistance</article-title>
          <source>Clin Infect Dis</source>
          <volume>48</volume>
          <fpage>667</fpage>
          <lpage>676</lpage>
          <pub-id pub-id-type="pmid">19191655</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
